Lion achieved sales of \u00a5688 million (YoY +3.9%) in the first quarter of fiscal year ending March 2027, with strong performance in the medical and environmental equipment businesses. Total assets and liabilities also increased, maintaining solid financial performance.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6823","jir_company_name":"Lion Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/6823-20260730-01.pdf","jir_short_summary":"Lion achieved sales of \u00a5688 million (YoY +3.9%) in the first quarter of fiscal year ending March 2027, with strong performance in the medical and environmental equipment businesses. Total assets and liabilities also increased, maintaining solid financial performance.","jir_summary":"### Performance Overview\nLion recorded sales of \u00a5688 million (YoY +3.9%) in the first quarter of fiscal year ending March 2027, with steady growth in its medical and environmental equipment businesses. Corresponding increases in total assets and liabilities indicate a stable financial foundation. The medical equipment segment saw strong sales of hearing aids and testing devices, while the environmental equipment segment also contributed to revenue growth.\n\n### Future Outlook and Shareholder Impact\nThe company plans to continue expanding its product lineup in the medical and environmental sectors and develop new businesses, expecting steady performance. Given the increase in revenue and financial stability, dividends and stock price appreciation are anticipated for shareholders. The company will actively invest for medium- to long-term growth and aim to enhance shareholder value.","jir_financial_highlights":"Sales: \u00a5688 million (+3.9%)\nOperating Income: 829 million yen (unknown)\nNet Assets: \u00a535,242 million (increase)","jir_category":"","jir_hashtags":"#Lion, #FinancialSummary, #JapanStocks","jir_key_figures":"Sales: \u00a5688 million (YoY +3.9%)\nNet Assets: \u00a535,242 million (increase)\nOperating Income: 829 million yen (unknown)","jir_meta_title":"\u3010Lion\u3011First Quarter of Fiscal Year Ending March 2027 \uff5c Sales of \u00a5688 million (+3.9%)","jir_meta_description":"Lion achieved sales of \u00a5688 million (YoY +3.9%) in the first quarter of fiscal year ending March 2027, with strong growth in medical and environmental businesses. Financial performance remains stable.","jir_og_title":"Lion 2027 Q1 Earnings\uff5cSales of \u00a5688 million +3.9%","jir_og_description":"Lion recorded sales of \u00a5688 million (+3.9%) in Q1 2027. Growth in the medical and environmental sectors and financial stability support future expansion.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":57169,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-90585","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n